CRYOLIFE INC (CRY) Stock Price, Forecast & Analysis

NYSE:CRY

17.88
+0.25 (+1.42%)
At close: Jan 21, 2022
17.88
0 (0%)
After Hours: 1/21/2022, 8:51:04 PM

CRY Key Statistics, Chart & Performance

Key Statistics
Market Cap703.22M
Revenue(TTM)358.43M
Net Income(TTM)-1.33M
Shares39.33M
Float37.61M
52 Week High32.34
52 Week Low16.95
Yearly Dividend0
Dividend Yield0%
EPS(TTM)0.3
PE59.6
Fwd PE265.53
Earnings (Next)02-10
IPO1993-02-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
CRY short term performance overview.The bars show the price performance of CRY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

CRY long term performance overview.The bars show the price performance of CRY in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20 -25

The current stock price of CRY is 17.88 null. In the past month the price decreased by -10.29%. In the past year, price decreased by -29.19%.

CRYOLIFE INC / CRY Daily stock chart

CRY Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
CRY Full Technical Analysis Report

CRY Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to CRY. There are concerns on the financial health of CRY while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CRY Full Fundamental Analysis Report

CRY Financial Highlights

Over the last trailing twelve months CRY reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 130.77% compared to the year before.


Industry RankSector Rank
PM (TTM) -0.37%
ROA -0.16%
ROE N/A
Debt/Equity 1
Chartmill High Growth Momentum
EPS Q2Q%-138.46%
Sales Q2Q%10.87%
EPS 1Y (TTM)130.77%
Revenue 1Y (TTM)40.55%
CRY financials

CRY Forecast & Estimates

8 analysts have analysed CRY and the average price target is 33.09 null. This implies a price increase of 85.05% is expected in the next year compared to the current price of 17.88.

For the next year, analysts expect an EPS growth of -91.22% and a revenue growth 18.02% for CRY


Analysts
Analysts82.5
Price Target33.09 (85.07%)
EPS Next Y-91.22%
Revenue Next Year18.02%
CRY Analyst EstimatesCRY Analyst Ratings

CRY Ownership

Ownership
Inst Owners91.55%
Ins Owners5.73%
Short Float %N/A
Short RatioN/A
CRY Ownership

CRY Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.95200.474B
ISRG INTUITIVE SURGICAL INC48.33174.759B
SYK STRYKER CORP25.22147.128B
BSX BOSTON SCIENTIFIC CORP21.46110.292B
BDX BECTON DICKINSON AND CO11.5852.52B
IDXX IDEXX LABORATORIES INC43.8249.757B
EW EDWARDS LIFESCIENCES CORP27.7247.84B
GEHC GE HEALTHCARE TECHNOLOGY16.7338.219B
RMD RESMED INC20.4937.992B
DXCM DEXCOM INC28.9528.573B

About CRY

Company Profile

CRY logo image CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. The company is headquartered in Kennesaw, Georgia and currently employs 1,200 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The firm operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.

Company Info

CRYOLIFE INC

1655 Roberts Blvd NW

Kennesaw GEORGIA 30144 US

CEO: J. Patrick Mackin

Employees: 1200

CRY Company Website

Phone: 17704193355.0

CRYOLIFE INC / CRY FAQ

What does CRY do?

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. The company is headquartered in Kennesaw, Georgia and currently employs 1,200 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The firm operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.


What is the stock price of CRYOLIFE INC today?

The current stock price of CRY is 17.88 null. The price increased by 1.42% in the last trading session.


Does CRY stock pay dividends?

CRY does not pay a dividend.


What is the ChartMill technical and fundamental rating of CRY stock?

CRY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the sector and industry classification for CRYOLIFE INC?

CRYOLIFE INC (CRY) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Is CRYOLIFE INC (CRY) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CRY.


Can you provide the market cap for CRYOLIFE INC?

CRYOLIFE INC (CRY) has a market capitalization of 703.22M null. This makes CRY a Small Cap stock.